Home Page
Chairman's Letter
Committees
Opening Lectures
International Society of Heart
Failure Awards

Thanks
General Information
Social Program
List of Exhibitors
Scientific Program
Satellite Symposium
Monday, July 10, 2000
Registration Form
Accommodation
Form (Word Document)
Back to CARDIOLOGY ONLINE
  SCIENTIFIC PROGRAM

MONDAY,
JULY 10, 2000

TUESDAY, 
JULY 11, 2000

WEDNESDAY,
JULY 12, 2000

 

TUESDAY, JULY 11, 2000
08:30-10:45   HALL A
PL06:  Plenary Session:
CARDIOMYOPATHIES: HYPERTROPHIC AND DILATED
Chairpersons: U. Elkayam, Los Angeles CA, USA
E.D. Wigle, Toronto, Ontario, Canada		  
    Abstract Page
08:30  MECHANISMS & MANAGEMENT OF CONGESTIVE HEART FAILURE IN HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
E.D. Wigle, Toronto ON, Canada		  54
08:45  TRANSCORONARY ABLATION OF SEPTUM HYPERTROPHY (TASH) FOR HOCM: AN ALTERNATIVE TO OPERATION AND PACEMAKER THERAPY (Invited Lecture)
H.J. Kuhn, F. Gietzen, C. Leuner, L. Obergassel, F. Lieder, C. Strunck-Mueller, Bielefeld, Germany 		 54
09:00  CURRENT SURGICAL MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
H.V. Schaff, Rochester MN, USA		  55
09:15  PERIPARTUM CARDIOMYOPATHY (Invited Lecture)
U. Elkayam, Los Angeles CA, USA 		 55
09:30  OBESITY CARDIOMYOPATHY (Invited Lecture)
M.A. Alpert, Mobile AL, USA		  55
09:45  OXIDATIVE STRESS IN THE PATHOPHYSIOLOGY OF ADRIAMYCIN-INDUCED CONGESTIVE HEART FAILURE (Invited Lecture)
P.K. Singal, Winnipeg MB, Canada 		 55
10:00  SPECIFIC INFILTRATIVE CARDIOMYOPATHY CONCOMITANT WITH PERICARDIAL EFFUSION IN PATIENTS WITH B-THALASSEMIA (Invited Lecture)
A. Hourzamanis, N.J. Angomachalelis, R. Zacharski, M. Angelski, T. Mesimeris, E. Serasli, Thessaloniki, Greece 		 56
10:15  VIRAL MYOCARDITIS AND DILATED CARDIOMYOPATHY (Invited Lecture)
N. Kipshidze, Tbilisi, Georgia 		 56
10:30  FUNCTIONAL ABNORMALITIES OF GAP JUNCTIONS IN CARDIOMYOPATHIC SYRIAN HAMSTERS: A ROLE OF TYROSINE PHOSPHORYLATION OF CONNEXIN-43 (Invited Lecture)
M. Hori, Osaka, Japan 		 56
10:45  Coffee Break  
TUESDAY, JULY 11, 2000
08:30-11:00   HALL B
S58:  Session:
VASCULAR ENDOTHELIAL FUNCTION, INFLAMMATORY MEDIATORS, CYTOKINES, NITRIC OXIDE, PHARMACOLOGIC MODULATION
Chairpersons: A. Lerman, Rochester MN, USA 
M.A. Rossi, Ribeirao Preto S.P., Brazil		  
    Abstract Page
08:30  ENDOTHELIAL FUNCTION FROM BENCH TO BEDSIDE (Invited Lecture)
A. Lerman, Rochester MN, USA		  56
08:45  CIRCULATING IMMUNOINFLAMMATORY GRADIENT IN PATIENTS WITH ADVANCED HEART FAILURE
G.B. Grossman, C.P. Campos, L.E. Rohde, N. Clausell, Porto Alegre, Brazil 		 57
09:00  ENDOTOXIN DEPRESSES MYOCARDIAL CONTRACTILITY OF ISOLATED RAT HEARTS VIA TNF-a SYNTHESIS: EVIDENCE FOR A ROLE OF SPHINGOSINE AND CYCLOOXYGENASE-2-DERIVED THROMBOXANE PRODUCTION
U. Grandel, U. Sibelius, A. Blum, L. Fink, M. Buerke, M. Rainer, M. Bohle, W. Seeger, F. Grimminger, Giessen, Mainz, Germany		  57
09:15  CHANGES IN THE PRODUCTION OF INFLAMMATORY RELATED CYTOKINES BY STATINS
A. Rezaie-Majd, J. Wojta, H.G. Kress, T. Maca, E. Minar, M. Baghestanian, Vienna, Austria 		 57
09:30  CARDIAC NITRIC OXIDE IS INCREASED IN PATIENTS WITH CHRONIC HEART
F. Masashi, N. Shinsuke, O. Tomoki, M. Takakazu, K. Junichi, W. Tetsuya, I. Nobuaki, N. Mayu, Y. Hideyuki, I. Akio, N. Seiki, K. Masafumi, N. Koichi, H. Masatsugu, Amagasaki, Suita, Japan 		 57
09:45  IMPROVEMENT IN ENDOTHELIUM-DEPENDENT FUNCTION IN PATIENTS WITH CLASS II & III ANGINA BY A MEDICAL FOOD
A.J. Maxwell, M.P. Zapien, B. Anderson, P.H. Stone, Boston MA, USA 		 58
10:00  CARNITINES INHIBITS OXYGEN FREE RADICAL RELEASE BY ENDOTHELIAL CELL AND LEUKOCYTES
E. Rossi, C. Caroselli, L. Loffredo, A. Picca, S. Natoli, F. Violi, Rome, Italy 		 58
10:15  EFFECTS OF ACUTE ESTROGEN ADMINISTRATION ON THE CARDIAC PERFORMANCE OF PATIENTS WITH CHRONIC HEART FAILURE
D. Leftheriotis, S. Adamopoulos, E. Sbarouni, G. Karavolias, D.T. Kremastinos, Athens, Greece 		 58
10:30  EFFECTS OF ATORVASTATIN ON FIBRINOLYTIC SYSTEM IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
L. Pucci, S. Bandinelli, D. Lucchesi, F. Caricato, R. Navalesi, A. Bertolotto, G. Penno, Pisa, Italy 		 58
10:45  MICROVESSEL WALL PERMEABILITY IMPROVES IN PRIMARY HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH ATORVASTATIN
S. Bandinelli, A. Bertolotto, L. Pucci, R. Navalesi, G. Penno, Pisa, Italy		  59
11:00  Coffee Break  
TUESDAY, JULY 11, 2000
08:30-10:15    HALL D
S60:  Session:
EXERCISE PHYSIOLOGY AND REHABILITATION IN HEART FAILURE
Chairpersons: O. Abdel-Aziz, Cairo, Egypt Abstract Page
M. Shechter, Tel Hashomer, Israel		  
    Abstract Page
08:30  DOES BETA BLOCKADE THERAPY MODIFY EXERCISE INTENSITY PRESCRIPTION IN CONGESTIVE HEART FAILURE?
D. Curnier, M. Galinier, A. Pathak, J. Fourcade, M. Bousquet, J.-M. Fauvel, J.-M. Senard, J.P. Bounhoure, J.-L. Montastruc, Toulouse, St. Orens, France		  59
08:45  VENTILATORY AND PERIPHERAL COMPONENTS OF IMPROVED VO2MAX IN PATIENTS WITH HEART FAILURE
T.R. McConnell, J.S. Mandak, J.S. Sykes, H. Fesniak, H. Dasgupta, Danville PA, USA 		 59
09:00  VARIOUS REHABILITATION PROGRAMS IN CONGESTIVE HEART FAILURE
B. Bacior, A. Kubinyi, W.M. Szot, A. Klecha, J. Skula, K. Kawecka-Jaszcz, Krakow, Poland 		 59
09:15  THE EFFECTS OF A SELF MONITORED PHYSICAL TRAINING PROGRAM ON EXERCISE PERFORMANCE AND ON SYMPATHETIC ACTIVITY IN PATIENTS WITH HEART FAILURE
R.B. Herman, S.A. Behzad, A. Doci, I.K.S. Chua, V.T. Johgalingam, A.M. Mustafa, I.R. Husain, A.M. Choy, C.C. Lang, Andalas, Indonesia, Kuala Lumpur, Malaysia		  60
09:30  DIFFERENCES IN CARDIOPULMONARY INDICES BETWEEN PATIENTS WITH LV DYSFUNCTION WITH NO ISCHEMIA AND PATIENTS WITH SIGNIFICANT ISCHEMIA AND GOOD LV FUNCTION DURING EXERCISE
E. Klainman, J. Lebzelter, G. Fink, N. Zafrir, M.R. Kramer, Givataim, Petah Tiqva, Israel		  60
09:45  CHANGES IN QUALITY OF LIFE IN MEN WITH HEART FAILURE DURING REGULAR PHYSICAL TRAINING
A. Kubinyi, M. Klocek, B. Bacior, W.M. Szot, K. Kawecka-Jaszcz, Krakow, Poland		  60
10:00  EFFECTS OF LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTION ON EXERCISE CAPACITY IN PATIENTS WITH SURVIVORS OF ANTERIOR MYOCARDIAL INFARCTION
M. Kabukcu, E. Yanik, F. Demircioglu, A. Belgi, O. Sancaktar, F. Ersel, Antalya, Turkey 		 60
10:15  Coffee Break  
TUESDAY, JULY 11, 2000
11:00-13:00   HALL A
PL07:  Plenary Session:
MYOCARDIAL REVASCULARIZATION: NEWER INTERVENTIONAL TECHNIQUES
W. Ganz, Los Angeles CA, USA
H.J. Kuhn, Bielefeld, Germany		  
    Abstract Page
11:00  THROMBOLYSIS: VIEW FROM THE BENCH AND THE BEDSIDE (Invited Lecture)
W. Ganz, Los Angeles CA, USA		  61
 11:15  HOW DO WE AVOID LOSING MYOCARDIAL CELLS DURING PERCUTANEOUS INTERVENTION IN CORONARY SYNDROMES? (Invited Lecture)
P.C. Block, Portland OR, USA		  61
11:30  CARDIAC GENE THERAPY: PROMISES FOR THE NEW CENTURY (Invited Lecture)
T.K. Rosengart, New York NY, USA		  61
11:45  BEYOND MORPHOLOGY: NEW CORONARY PHYSIOLOGIC APPROACHES TO INTERVENTIONS (Invited Lecture)
V. Klauss, Munich, Germany 		 62
12:00  THE ROLE OF ULTRASOUND IN CORONARY STENTING (Invited Lecture)
H. Mudra, A. Knape, C. Spes, Munich, Germany 		 62
12:15  ANGIOPLASTY OF INFARCT RELATED ARTERY IN AMI: EFFICIENT OR EFFECTIVE (IMPRESSIVE) ONLY? (Invited Lecture)
D.G. Iosseliani, Moscow, Russia		  62
12:30  INTRAVASCULAR BRACHYTHERAPY WITH RHENIUM-188 BALLOON: RADIANT PILOT STUDY (Invited Lecture)
R.R. Makkar, J. Whiting, A. Li, J. Hausleiter, A. Robinson, N. Eigler, Los Angeles, CA, USA 		 62
12:45  EARLY STENTING AFTER THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION - FIRST RESULTS OF A RANDOMIZED STUDY
B. Hennen, B. Scheller, B. Hammer, J. Hofer, Homburg/Saar, Germany 		 63
13:00  Lunch Break  
TUESDAY, JULY 11, 2000
11:00-12:45    HALL B
S61:  Session:
MOLECULAR BIOLOGY: GENETIC STUDIES, APOPTOSIS
Chairpersons: N.S. Dhalla, Winnipeg Manitoba, Canada
W.J. Koch, Durham NC, USA		  
     Abstract Page
11:00  DIFFERENTIAL GENE EXPRESSION OF ANP AND ADRENOMEDULLIN IN ISOPROTERENOL INDUCED CARDIAC HYPERTROPHY IN RATS
M. Toth, Z. Lako-Futo, G. Foldes, I. Szokodi, H. Ruskoaho, Z. Bori, R. deChatel, Budapest, Hungary 		 63
11:15  A NEW HIGH RESOLUTION ECG RECORDING TECHNIQUE FOR EVALUATION OF CARDIAC CONDUCTION AND REFRACTORINESS IN ISOLATED PERFUSED MICE HEARTS
A. Lueger, G. Stark, M. Brodmann, D. Scherr, R. Gasser, H. Tritthart, Graz, Austria		  63
11:30  DNA FRAGMENTATION FACTOR DFF45/ICAD IS UPREGULATED IN CARDIOMYOCYTES ISOLATED FROM EXPLANTED FAILED HUMAN HEARTS
A. Todor, V.G. Sharov, R.C. Gupta, S. Mishra, N. Silverman, S. Goldstein, H.N. Sabbah, Detroit MI, USA 		 63
11:45  POSTISCHEMIC APOPTOSIS AND FUNCTIONAL RECOVERY AFTER ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKADE IN THE ISOLATED WORKING RAT HEART
S. Musat-Marcu, R. Moudgil, B.I. Jugdutt, Edmonton AB, Canada		  64
12:00  INTERLEUKIN-6/SOLUBLE INTERLEUKIN-6 RECEPTOR COMPLEX INHIBITS MYOCARDIAL APOPTOSIS
K. Matsushita, S. Iwanaga, T. Oda, K. Kimura, M. Shimada, M. Tanaka, S. Matsumura, S. Ogawa, Tokyo, Japan		  64
12:15  DOES ENTEROVIRUS INFECTION PROTECT MYOCARDIUM FROM APOPTOSIS?
P. Alter, E. Meyer, M. Jobmann, B. Maisch, Marburg/Lahn, Germany 		 64
12:30  THE ROLE OF HOST IMMUNOGENETIC FACTORS IN THE SUSCEPTIBILITY AND PATHOGENESIS OR RHEUMATIC HEART DISEASE
M. Kotb, Y. Guedez, M. El-Demellawy, Memphis TN, USA 		 64
12:45  Lunch Break  
TUESDAY, JULY 11, 2000
11:00-13:00    HALL C
S59:  Session:
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME
Chairpersons: P.C. Deedwania, Fresno CA, USA 
R.E. Hobbs, Cleveland OH, USA		  
    Abstract Page
11:00  EFFECT OF CAPTOPRIL VS LOSARTAN ON PLASMA BIG ENDOTHELIN IN CHRONIC HEART FAILURE (NEUROHUMORAL SUBSTUDY ELITE ID
R. Pacher, B. Stanek, C. Benedict, Vienna, Austria, Houston TX, USA		  65
11:15  IMPACT OF BUNDLE BRANCH BLOCK (BBB) PATTERN ON EKG ON SURVIVAL IN PATIENTS WITH CONGESTIVE HEART FAILURE (CHF). AN EIGHT YEAR FOLLOW UP STUDY
S.A. Hassan, D. Nori, S. Bhatt, S. Borzak, A. Philbin, W.D. Weaver, S. Soman, S. Shah, P.A. McCullough, Detroit MI, USA 		 65
11:30  TRIIODOTHYRONINE EFFECTS ON HUMAN CARDIOMYOCYTE PHENOTYPE AND INTRACELLULAR CALCIUM HOMEOSTASIS
F. Forini, T. Pizzorusso, G.M. Ratto, V. Vanini, G. Iervasi, Pisa, Massa, Italy 		 65
11:45  SENSITIVITY AND SPECIFICITY OF QRS DURATION TO PREDICT ACUTE BENEFIT IN HEART FAILURE PATIENTS WITH VENTRICULAR RESYNCHRONIZATION
V. Kadhiresan, J. Vogt, A. Auricchio, C. Butter, C. Stellbrink, J. Spinelli, J. Ding, L. Liu, A. Doegler, Bad Oyenhausen, Germany, St. Paul MN, USA 		 65
12:00  HEART RATE VARIABILITY IN CONGESTIVE HEART FAILURE: DOES ITS DECREASE CORRELATE TO HEMODYNAMIC PARAMETERS AT REST AND DURING EXERCISE?
F. Edelmann, C. Weinbrenner, M. Knapp, G. Simonis, R.H. Strasser, Heidelberg, Germany 		 66
12:15  CARDIAC OUTCOMES WITH OUTPATIENT INOTROPIC INFUSIONS IN PATIENTS WITH SEVERE HEART FAILURE
K. Vijayaraghavan, S. Crumm, Q. Helgeson, Phoenix AZ, USA 		 66
12:30  THE T, THE I, OR BOTH OF THEM: A NOVEL MULTI-MARKER APPROACH IN CONGESTIVE HEART FAILURE
E.D. Missov, D.M. Lau, T. De Marco, San Francisco CA, USA		  66
12:45  AUTONOMIC MODULATION IN SEVERE HEART FAILURE
A.F. Folino, V. Kitenge, A. Porta, S. Cerutti, B. Tokajuk, S. Dalla Volta, Padua, Milan, Italy 		 66
  Lunch Break  
TUESDAY, JULY 11, 2000
11:00-12:30    HALL D
S63:  Session:
CARDIAC TRANSPLANTATION
Chairpersons: B. Heublein, Hannover, Germany 
B.M. Meiser, Munich, Germany		  
    Abstract Page
11:00  TGF-a1 AND PAI-1 GENE POLYMORPHISMS IN RELATION TO CORONARY ARTERY DISEASE BEFORE AND AFTER CLINICAL HEART TRANSPLANTATION
C.C. Baan, P.W.M. Hermans, C.T.J. Holweg, A.P.W.M. Maat, W. Weimar, A.H.M.M. Balk, Rotterdam, The Netherlands 		 67
11:15  LEFT VENTRICULAR DYSFUNCTION DURING ACCELERATED TRANSPLANT CORONARY ARTERY DISEASE: RELATIVE IMPORTANCE OF DIFFUSE DISTAL VESSEL OBLITERATION
M. Dandel, E. Wellnhofer, J. Mueller, M. Hummel, R. Hetzer, Berlin, Germany 		 67
11:30  FAILURE OF ACUTE IMPROVEMENT OF RIGHT VENTRICULAR FUNCTION DURING PROSTAGLANDIN E1 (PGE1) INFUSION PREDICTS SEVERE LV-DYSFUNCTION PATIENTS FOR URGENT TRANSPLANTATION
M. Hulsmann, T. Stefenelli, R. Berger, B. Sturm, A. Zukermann, W. Woloszczuk, R. Pacher, Vienna, Austria		  67
11:45  HEART TRANSPLANT OUTCOME IS WORSE USING GENDER MISMATCHED GRAFTS: AN RISK FACTOR ANALYSIS OF 640 CARDIAC TRANSPLANTS
B. Schlechta, A.A. Kocher, Y. Kaneko, M. Ploner, F. Nourani, M. Grimm, E. Wolner, G. Laufer, Vienna, Austria 		 67
12:00  REGIONAL PERFUSION OF THE PORCINE MYOCARDIUM BEFORE AND AFTER ORTHOTOPIC HEART TRANSPLANTATION
P. Sommer, M. Siepe, J. Hilberath, J. Martin, K. Sarai, C. Ihling, F. Beyersdorf, Freiburg, Germany		  68
12:15  ATORVASTATIN THERAPY FOR HYPERLIPIDEMIA AFTER ORTHOTOPIC CARDIAC TRANSPLANTATION
G. Bhat, J. Brohm, L. Muncy, K. Erbeck, G.R. Aronoff, Louisville KY, USA 		 68
12:30  Lunch Break  
TUESDAY, JULY 11, 2000
08:30-13:00    POSTER AREA
P301:  Poster Session:
MOLECULAR BIOLOGY AND BIOCHEMICAL ASPECTS OF HEART FAILURE		  
Board No.    Abstract Page
1  COULD UTROPHIN RESCUE THE DYSTROPHIN-DEFICIENCY?
P. Melacini, M. Fanin, A. Barchitta, C. Angelini, G.A. Danieli, S. Dalla Volta, Padua, Italy		  68
2  THE MODULATION OF L-TYPE CARDIAC CA CHANNEL BY PROTEIN KINASE A AND A ANCHORING PROTEIN
T. Yamakawa, K. Kobayashi, M. Mori, Y. Fukuda, T. Furukawa, T. Teramoto, T. Sato, Tokyo, Japan 		 68
3  LEPTIN SERUM LEVELS ARE NOT INCREASED IN CACHECTIC HEART FAILURE PATIENTS
K. Tsilias, G. Filippatos, K. Venetsanou, J. Koutras, D. Manolatos, E. Karambinos, D. Economou, A. Kranidis, N. Sfougaris, F. Kardaras, L. Anthopoulos, G. Baltopoulos, Athens, Greece		  69
4  EFFECTS OF LOW ALTITUDE ON OXYGEN FREE RADICALS ACTIVITY IN CHRONIC CONGESTIVE HEART FAILURE PATIENTS
E. Goldhammer, S. Shnitzer, N. Kleiman, A. Lanir, E.G. Abinader, Haifa, Israel 		 69
5  DIFFERENCES IN SARCOPLASMIC RETICULUM GENE EXPRESSION IN DIASTOLIC HEART FAILURE IN RABBIT
Y. Zhang, M. Zhong, W. Zhang, Z. Geng, G. Zhang, J. Zhao, X. Ji, Jinan, China		  69
6  THE ULTRASTRUCTURAL BASIS OF HEART FAILURE IN EXPERIMENTAL ATHEROSCLEROSIS
N.N. Kipshidze, N. Kakauridze, Z. Tsagareli, L. Gogiashvili, Tbilisi, Georgia		  69
TUESDAY, JULY 11, 2000
08:30-13:00    POSTER AREA
P302:  Poster Session:
ECHOCARDIOGRAPHY, DOPPLER MEASUREMENTS		  
Board No.    Abstract Page
7  ECHOCARDIOGRAPHIC DIAGNOSIS OF RUPTURED AND ANRUPTURED SINUS OF VALSALVA ANEURYSM: 10 YEARS EXPERIENCE
C. Ginghina, E. Apetrei, I. Stoian, M. Marinescu, D. Queshta, I. Kulcsar, F. Paraschiva, B. Fotiade, Bucharest, Romania		  70
8  CAN ATROPINE BE GIVEN IN EARLIER STAGES DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND THEREFORE SHORTEN THE TEST TIME PERIOD?
H.R. Villarrega, F. Rosso, P. Olaya, J. Sanchez, M. Badiel, Cali, Colombia 		 70
9  EARLY DETECTION OF MYOCARDIAL ISCHEMIA DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY USING COLOR CODED TISSUE DOPPLER IMAGING
M. Harada, M. Nasu, A. Tashiro, S. Kuriki, K. Hiramori, Morioka, Japan 		 70
10  STRESS ECHOCARDIOGRAPHY IN OCTOGENARIANS: SAFETY, TOLERABILITY AND BETTER VISUALIZATION OF THE MYOCARDIAL SEGMENTS USING NATIVE HARMONICS
H.R. Villarraga, P. Olaya, J. Sanchez, F. Rosso, M. Badiel, Cali, Colombia		  70
11  PROGNOSIS OF STRESS ECHOCARDIOGRAPHY IN OCTOGENARIANS WITH METHODS OF BETTER VISUALIZATION OF THE MYOCARDIAL SEGMENTS
H.R. Villarraga, A.J. Lores, P. Olaya, J. Sanchez, M. Badiel, F. Rosso, Cali, Colombia 		 71
12  CAN ECHOCARDIOGRAPHY OFFER A COHERENT INTERPRETATION OF VARIOUS ENTITIES INCLUDED IN RESTRICTIVE CARDIOMYOPATHY?
C. Ginghina, E. Apetrei, I. Stoian, M. Marinescu, D. Qeshta, I. Kulcsar, V. Ene, D. Deleanu, L. Zarma, Bucharest, Romania		  71
  COMPARISON OF DIFFERENT ECHOCARDIOGRAPHIC PARAMETERS AND CLINICAL STATUS IN PATIENTS WITH DILATED CARDIOMYOPATHY
J.B. Dahm, E. Kuon, P.-N. Niederst, S. Raeth, Greifswald, Ebermannstadt, Hameln, Germany 		 71
14  STRESS ECHOCARDIOGRAPHY: WHICH OF THE CORONARY REGIONS ARE ENHANCED BY NATIVE HARMONICS DURING REST AND PEAK IMAGE ACQUISITION IN BOTH PHARMACOLOGICAL AND EXERCISE MODALITIES WHEN COMPARED TO FUNDAMENTAL IMAGING?
H.R. Villarraga, F. Rosso, J. Sanchez, P. Olaya, M. Badiel, Cali, Colombia 		 71
15  THE EVALUATION OF CARDIAC FUNCTION DURING CARDIOPULMONARY BYPASS USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY
H. Kubota, A. Furuse, Y. Kotsuka, S. Umezu, S. Takamoto, Tokyo, Japan 		 72
16  APPROXIMATION TO DIASTOLIC CORONARY FLOW VELOCITY FROM ILLEGIBLE RECORDING BY TRANSTHORACIC PULSED DOPPLER ECHOCARDIOGRAPHY
S. Kuriki, M. Nasu, A. Tashiro, M. Harada, K. Hiramori, Fukushima, Japan 		 72
17  EVALUATION OF THE OPTIMAL DOSE OF INTRACORONARY ADENOSINE 5'-TRIPHOSPHATE FOR THE MEASUREMENT OF CORONARY FLOW RESERVE
T. Furuta, H. Yokoi, S. Mori, S. Kakizawa, W. Fujiwara, A. Sugiura, O. Inami, T. Kondo, Y. Abo, Y. Watanabe, Nagoya, Japan 		 72
TUESDAY, JULY 11, 2000
08:30-13:00    POSTER AREA
P302:  Poster Session:
ECHOCARDIOGRAPHY, DOPPLER MEASUREMENTS (cont'd)		  
Board No.    Abstract Page
18  THE RELATION BETWEEN ST SEGMENT ELEVATION SHAPE AND BOTH OF LOW DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND CLINICAL COURSE IN EARLY PERIOD OF ANTERIOR MYOCARDIAL INFARCTION
A. Karadede, A.V. Temamogullari, O. Aydinalp, M.S. Ulgen, S. Algan, K. Itumur, N. Toprak, Diyarbakir, Turkey 		 72
19  USE OF NEW ECHOCARDIOGRAPHIC PARAMETERS IN THE EVALUATION OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
S. Bayata, A. Pinar, U.A. Turk, I. Susam, M.H. Dinckal, N. Postaci, M. Yesil, Izmir, Turkey 		 73
20  INCIDENCE OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IDENTIFIED BY ECHOCARDIOGRAPHY DURING EVALUATION OF UNEXPLAINED HYPOTENSION IN CONSECUTIVE PATIENTS
S. Verma, O.U. Rehman, G.A. Mensah, J.R. Gossage, V.B. Shah, Augusta GA, USA 		 73
TUESDAY, JULY 11, 2000
08:30-13:00    POSTER AREA
P303:  Poster Session:
HEART FAILURE IN VALVULAR HEART DISEASE		  
Board No.    Abstract Page
21  MITRAL VALVE REPLACEMENT OR REPAIR WITH OR WITHOUT MAZE PROCEDURE-FOLLOW UP STUDY
R. Bachowski, T. Mandecki, S. Wo, M. Skowerski, M. Matuszewski, W. Domaradzki, Katowice, Poland 		 73
22  EFFECTS OF EXERCISE ON TRANSMITRAL GRADIENT AND PULMONARY ARTERY PRESSURE IN PATIENTS WITH MITRAL STENOSIS AND ATRIAL FIBRILLATION
M. Kabukcu, F. Demircioglu, I. Ates, E. Yanik, E. Arslantas, A. Belgi, O. Sancaktar, O. Beyazit, F. Ersel, Antalya, Turkey		  73
23  EFFECTS OF CARDIOVERSION AND PERSISTENT SINUS RHYTHM ON LEFT VENTRICULAR GEOMETRY AND LEFT ATRIAL DIAMETER IN PATIENTS WITH MITRAL STENOSIS AND ATRIAL FIBRILLATION
M. Kabukcu, F. Demircioglu, I. Ates, E. Yanik, E. Arslantas, A. Belgi, O. Sancaktar, O. Beyazit, F. Ersel, Antalya, Turkey 		 74
24  THE ROLES OF AORTIC VALVE THICKENING AND SUBVALVULAR STENOSIS IN THE ETIOLOGY OF AORTIC VALVE REGURGITATION
H. Matsuoka, Nagasaki, Japan 		 74
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P303:  Poster Session:
HEART FAILURE IN VALVULAR HEART DISEASE (cont'd)		  
Board No.    Abstract Page
25  SHOULD SYMPTOMS GUIDE SURGERY IN PATIENTS WITH SEVERE CHRONIC AORTIC REGURGITATION?
F. Tarasoutchi, M. Grinberg, P. Pomerantzeff, L.F. Cardoso, G.S. Spina, W.S. Avila, E.G. Rossi, P.L. da Luz, Sao Paulo, Brazil 		 74
26  THE VALUE OF TEE IN PLANING AORTIC VALVE REPAIR OR REPLACEMENT IN PTS OPERATED ON TYPE A AORTIC DISSECTION WITH AORTIC REGURGITATION - 10 YEARS ECHOCARDIOGRAPHIC STUDY
M. Maciejewski, K. Piestrzeniewicz, M. Zielinska, P. Dejak, W. Koniarek, J.K. Wranicz, R. Jaszewski, J. Zaslonka, H. Bolinska, Lodz, Poland 		 74
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P304:  Poster Session:
PROGNOSTIC ASPECTS OF HEART FAILURE		  
Board No.    Abstract Page
27  CARDIAC LATE POTENTIALS AMONG HEART FAILURE PATIENTS
B. Bart, V. Larin, V. Larina, E. Krasnokutskaya, Moscow, Russia 		 75
28  MORTALITY OF CONGESTIVE HEART FAILURE PATIENTS IN HOSPITAL INCREASES DURING INFLUENZA-PREVALENT PERIODS
M. Narukawa, K.K. Minezaki, H. Komatu, M. Nakamura, M. Naitoh, S. Hagiwara, Y. Shigeta, M. Okubo, Tochigi, Japan		  75
29  PROGNOSTIC VALUE OF LEFT VENTRICULAR POSTINFARCTION REMODELING IN DEVELOPMENT OF CHF
Y. Martinov, A. Vasyuk, A. Hadzegova, P. Krikunov, M. Kopeleva, E. Louchtchouk, K. Sologub, Moscow, Russia 		 75
30  PROGNOSTIC VALUE OF ATRIAL FIBRILLATION IN THE PATIENTS WITH RESIDUAL ISCHEMIA
M. Dolzhenko, V. Bobrov, A. Kostyrya, S. Bilets'ky, Kiev, Ukraine 		 75
31  NITRATE USE DOES NOT IMPROVE CLINICAL OUTCOMES FOLLOWING HOSPITALIZATION FOR HEART FAILURE
E.F. Philbin, T.A. Rocco Jr., P.L. Jenkins, Detroit MI, Rochester NY, USA 		 76
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
 
P305:  Poster Session:
EXERCISE PHYSIOLOGY AND REHABILITATION IN HEART FAILURE		  
Board No.    Abstract Page
32  CARDIAC REHABILITATION WITHOUT ENTRY EXERCISE TESTS IS SAFE AS WELL AS OUTCOME EFFECTIVE AND COST EFFECTIVE
T.R. McConnell, C.A. Laubach Jr., F.J. Menapace, Danville PA, USA		  76
33  REHABILITATION OF CONGESTIVE HEART FAILURE: IMPACT OF THE ETIOLOGY
D. Curnier, M. Galinier, A. Pathak, J. Fourcade, M. Bousquet, J.-M. Fauvel, J.-M. Senard, J.-L. Montastruc, Toulouse, St. Orens, France		  76
34  INDIVIDUAL DISPERSION OF EXERCISE TRAINING INTENSITY IN CONGESTIVE HEART FAILURE: RELATION WITH THE VENTILATORY THRESHOLD
D. Curnier, M. Galinier, A. Pathak, J. Fourcade, M. Bousquet, J.-M. Fauvel, J.-M. Senard, J.-P. Bounhoure, J.-L. Montastruc, Toulouse, St. Orens, France 		 76
35  NON INVASIVE CARDIAC OUTPUT ESTIMATION DURING CARDIOPULMONARY EXERCISE TEST
S.M. Romano, F. Mazzuoli, M. Chiostri, M. Ciaccheri, G. Castelli, G. Camiciottoli, Florence, Italy 		 77
36  PROLONGED BENEFICIAL EFFECTS OF CAPOZIDE ON EXERCISE TOLERANCE AMONG CHRONIC HEART FAILURE PATIENTS
B. Bart, V. Larina, Moscow, Russia		  77
37  SKELETAL MUSCLE MASS IS AN INDEPENDENT PREDICTOR OF EXERCISE CAPACITY IN CHRONIC HEART FAILURE
M. Cicoira, L. Zanolla, L. Franceschini, A. Rossi, G. Golia, P. Zeni, Verona, Italy 		 77
TUESDAY, JULY 11, 2000
08:30 - 13:00    POSTER AREA
P306:  Poster Session:
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY I		  
Board No.    Abstract Page
38  REVERSIBLE BLOCK AS A METHOD FOR LOCATION OF ATRIAL FIBRILLATION SOURCE
P. Jakuska, R. Lekas, B. Olsson, R. Benetis, Kausan, Lithuania, Lund, Sweden		  77
39  COMBINED PHARMACOLOGICAL AND ABLATIVE THERAPY OF CLASS IC DRUG INDUCED ATRIAL FLUTTER IN PATIENTS WITH RESISTANT ATRIAL FIBRILLATION
A. Bonso, F. Giada, S. Themistoclakis, G. Gasparini, A. Corrado, A. Lo Presti, A. Raviele, Mestre-Venice, Italy 		 78
40  CURATIVE TREATMENT OF CHRONIC ATRIAL FIBRILLATION IN PATIENTS WITH SIMULTANEOUS CARDIOSURGICAL DISEASE WITH INTRAOPERATIVE MICROWAVE ABLATION
S.M. Tugtekin, M. Knaut, S.G. Spitzer, L. Karoly, H. Boehme, H. Raziq, S. Schueler, Dresden, Germany		  78
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P306:  Poster Session:
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY I (cont'd)		  
Board No.    Abstract Page
41  BERBERINE THERAPY FOR ISCHEMIC HEART FAILURE WITH COMPLICATING VENTRICULAR EXTRASYSTOLES BY MONITORING PLASMA BERBERINE CONCENTRATION
Y. Li, X. Zeng, X. Zeng, Y. Huang, Y. Yi, Chengdu, China 		 78
42  THE TREATMENT BY LOW-DOSE AMIODARONE AND CARVEDILOL IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND HEART FAILURE
G.-P. Jong, C.-Y. Chen, Taichung, Taiwan-R.O.C.		  78
43  THE RELATIONSHIP OF CARDIOVASCULAR COMPLAINTS WITH SIGNIFICANT CARDIAC ARRHYTHMIAS ON 24-HOLTER MONITORING IN THE YOUNG
R.E. Ramboyong, B. Matawaran, A.C.F. De Lara-Llarena, Manila, Philippines		  79
44  THE PRESENCE OF VENTRICULAR LATE POTENTIALS IN EARLY STAGE OF MYOCARDIAL INFARCTION IN PATIENTS WITH SERIOUS VENTRICULAR ARRHYTHMIAS - RELATION TO THE SITE OF INFARCTION
A. Kaasik, T. Ristimae, U. Soopold, R. Teesalu, Tartu, Estonia 		 79
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P307:  Poster Session:
PRACTICE GUIDELINES, COST CONTAINMENT		  
Board No.    Abstract Page
45  THE CANADIAN CHF CLINICS NETWORK: REFERRAL PRACTICES AND TREATMENT
A. Ignaszewski, J. Malcolm, O. Arnold, J.D. Parker, J. Howlett, S. Smith, W. Czarnecki, Vancouver BC, Canada		  79
46  IMPACT OF AN APPLIED CLINICAL PATHWAY ON PATIENTS ADMITTED WITH ACUTE CONGESTIVE HEART FAILURE TO A COMMUNITY CORONARY CARE UNIT
S. Lins, C. Draus, A. Walblay, Dearborn MI, USA		  79
47  COMPARISON OF OPTIMAL CARE FOR CONGESTIVE HEART FAILURE BETWEEN CARDIOLOGISTS AND INTERNISTS AT A CANADIAN UNIVERSITY TEACHING HOSPITAL
J.G. Howlett, J. Stanley, M. MacDonald, D.E. Johnstone, Halifax NS, Canada 		 80
48  MANAGING CHF: AN EVIDENCE AND OUTCOMES-BASED PHARMACY-MANAGED CLINIC
K. Findley, D. Frohnapple, Gainsville FL, USA 		 80
49  THE CHANGING PROFILE OF THE CONGESTIVE HEART FAILURE PATIENT: UTILITY OF COMMERCIAL CHF MANAGEMENT PROGRAMS
K.O. Akosah, A.M. Schaper, K. Briggs, S. Devine, R. Sundaram, La Crosse WI, USA 		 80
50  HEART FAILURE: MONITORING AND TELEMANAGEMENT - PAST, PRESENT AND FUTURE
S. Jacob, M. Mathew, Philadelphia PA, USA		  80
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P308:  Poster Session:
MISCELLANEOUS		  
Board No.    Abstract Page
51  SYMPATHETIC NERVE TRAFFIC AND LEFT VENTRICULAR MASS INDEX IN OBESE NORMOTENSIVE SUBJECTS AFTER BODY WEIGHT REDUCTION
I. Moyssakis, D. Drosos, G. Anastasiadis, T. Doduras, H. Kasparian, M. Kyriakidis, Athens, Greece 		 81
52  PLATELET ACTIVATING FACTOR PLAYS A CRITICAL ROLE IN DYNAMIC CARDIAC FUNCTIONAL AND STRUCTURAL ALTERATIONS IN THE INITIAL PHASE OF ENDOTOXEMIA
M. Iwase, L. Wang, C.S. Hui, K. Kiyoyuki, K. Takagi, T. Hasegawa, A. Noda, T. Nishizawa, T. Nagasaka, M. Yokota, Nagoya, Japan 		 81
53  AUDIT OF DIAGNOSTIC CARDIAC CATHETERISATION IN A DISTRICT GENERAL HOSPITAL
L.D.R. Smith, G. Spyer, J.W. Dean, Exeter, Devon, UK		  81
54  MYOCARDIAL INFARCTION IN VERY YOUNG (<30 YEARS) AND IN VERY ELDERLY PATIENTS (>70 YEARS)
M. Gencbay, K. Sonmez, R. Demirbag, M. Degertekin, F. Turan, Istanbul, Turkey		  81
55  THE SPIRONOLACTONE TEST
R. Lupescu, G. Lupescu Jr., E. Perciun, I. Epure, Tg. Jiu, Romania		  82
56  CHANGE IN MORTALITY RATES AND ITS EFFECT ON SURVIVAL TIME
G. Wendland, B. Hinzpeter, Koeln, Germany		  82
57  MORPHOLOGY OF ENDOCARDIAL MONOPHASIC ACTION POTENTIAL RECORDED FROM HUMAN RIGHT AND LEFT ATRIA
A. Murnan, D.T. Connelly, Liverpool, UK		  82
58  IMPACT OF SHORT-TERM ASPIRIN ON HEART RATE VARIABILITY IN HEALTHY MIDDLE-AGED MALES
T. Ristimae, R. Teesalu, Tartu, Estonia 		 82
TUESDAY, JULY 11, 2000
14:00-16:00    HALL A
PL08:  Plenary Session:
VASCULAR BIOLOGY AND NEUROHORMONAL MECHANISMS: BASIC RESEARCH AND CLINICAL ASPECTS
Chairpersons: S. Dalla Volta, Padova, Italy 
J.T. Willerson, Houston TX, USA		  
    Abstract Page
14:00  GENE THERAPY FOR THE INJURED VASCULAR ENDOTHELIUM (Invited Lecture)
J.T. Willerson, Houston TX, USA 		 83
14:15  THE ENDOTHELIAL DYSFUNCTION IN HEART FAILURE: THE BIOLOGICAL BASIS FOR TREATMENT (Invited Lecture)
S. Dalla Volta, D. Anzulovic-Mirosevic, M. Plebani, M. Zaninotto, S. Altinier, A. Capelletti, M. Mion, A. Rozga, Padua, Italy, Split, Croatia 		 83
14:30  CHRONIC INHIBITION OF NO SYNTHESIS INDUCES INTIMAL REMODELING IN THE AORTA OF NORMOCHOLESTEROLEMIC RATS (Invited Lecture)
M.A. Rossi, Sao Paulo, Brazil		  83
14:45  ANTIOXIDANT GENES: NOVEL THERAPEUTIC TARGETS FOR NITRIC OXIDE DONORS AND ASPIRIN (Invited Lecture)
H. Schroeder, Halle, Germany		  83
15:00  ENDOTHELIN-1 MODULATION OF SYMPATHETIC NERVE ACTIVITY IN HEART FAILURE (Invited Lecture)
I.H. Zucker, P.I. McConnell, J.-L. Liu, R. Pliquett, E. Brewer, Omaha NE, USA		  84
15:15  THE ROLE OF ALDOSTERONE ANTAGONISM IN ADVANCED HEART FAILURE: THE RESULTS OF THE RANDOMIZED ALDACTONE EVALUATION STUDY (RALES) (Invited Lecture)
P.C. Deedwania, Fresno CA, USA		  84
15:30  GENETIC DELETION OF NATRIURETIC PEPTIDE RECEPTOR-A AND CARDIOVASCULAR DISEASE (Invited Lecture)
K.N. Pandey, New Orleans LA, USA		  84
16:00  Coffee Break  
TUESDAY, JULY 11, 2000
14:00-16:15    HALL B
S64:  Session:
ISSUES SURROUNDING SURGICAL REVASCULARIZATION, HEART VALVE SURGERY AND CARDIAC TRANSPLANTATION
Chairpersons: V. Klauss, Munich, Germany 
M.A. Silver, Oak Lawn IL, USA		  
    Abstract Page
14:00  INTERCELLULAR AND VASCULAR CELL ADHESION MOLECULE LEVELS IN ENDOSCOPIC AND OPEN SAPHENOUS VEIN HARVESTING FOR CORONARY ARTERY BYPASS SURGERY
S.J. Alrawi, M. Samee, F. Balaya, R. Raju, D. Shirazian, A.J. Acinapaura, J.N. Cunningham, New York NY, USA		  85
14:15  BEATING VS. NON-BEATING HEART CARDIOPULMONARY BYPASS SURGERY
T.G. Sharp, P. Vijay, J.W. Brown, Indiana IN, USA		  85
14:30  ANGIOPLASTY VERSUS BYPASS SURGERY FOR CORONARY ARTERY DISEASE IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION - A META-ANALYSIS OF THE LITERATURE
R. Maraj, G. Crespo, M.N. Kotler, Philadelphia PA, USA		  85
14:45  ARTERIAL OFF-PUMP REVASCULARIZATION IN CRITICALLY ILL PATIENTS
H.-G. Wollert, K. Ansorge, H. Grubitzsch, L. Eckel, Karlsburg, Germany		  85
15:00  PREDICTORS OF SEVERE INTIMAL DISEASE IN RADIAL ARTERIES FOR USE IN CORONARY ARTERY SURGERY
P. Ruengsakulrach, R. Sinclair, I. Gordon, B. Buxton, Heidelberg, Australia		  86
15:15  LONGTERM USE OF PROSTAGLANDIN E1 IN ADVANCED HEART FAILURE
M. Huelsmann, B. Stanek, B. Sturm, A. Bojic, G. Locker, M. Grimm, G. Laufer, R. Pacher, Vienna, Austria		  86
15:30  LEFT VENTRICULAR DYSFUNCTION AND EXERCISE TOLERANCE IN NON-REJECTING HEART TRANSPLANT RECIPIENTS
M. Dandel, J. Mueller, M. Hummel, R. Ewert, R. Hetzer, Berlin, Germany		  86
15:45  PERCUTANEOUS TRANSLUMINAL LASER MYOCARDIAL REVASCULARIZATION COMBINED WITH PRESSURE ELEVATION IN THE MANAGEMENT OF UNSTABLE ANGINA PECTORIS
J.C. Han, Shen Zhen, China		  86
15:55  MITRAL VALVE REPAIR FOR MITRAL REGURGITATION IN BARLOW'S DISEASE USING THE DOUBLE ORIFICE TECHNIQUE
F. Maisano, O. Alfieri, Milan, Italy		  87
16:05  EARLY RESULTS OF EPICARDIAL RADIOFREQUENCY ABLATION OF CHRONIC ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY
S. Benussi, S. Nascimbene, C. Pappone, P. Stefano, O. Alfieri, Milan, Italy		  87
16:15  Coffee Break  
TUESDAY, JULY 11, 2000
14:00-16:00    HALL C
S65:  Session:
ARRHYTHMIAS - MECHANISMS AND MANAGEMENT
Chairpersons: J. Ge, Shanghai, China
J.L. Merino, Madrid, Spain		  
    Abstract Page
14:00  DOFETILIDE REDUCES HOSPITALISATIONS IN PATIENTS WITH ATRIAL FIBRILLATION AND LEFT VENTRICULAR DYSFUNCTION, A DIAMOND SUBSTUDY
O.D. Pedersen, Hellerup, Denmark		  87
14:15  DIAGNOSIS, MANAGEMENT AND OUTCOME OF ATRIAL FLUTTER IN THE PERINATAL AGE GROUP: A CONTROVERSIAL ISSUE
L.A. Lisowski, P.M. Verheijen, P. Stoutenbeek, A.A. Benatar, D.J.G. Soyeur, J.I. Brenner, C.S. Kleinman, E.J. Meijboom, Utrecht, The Netherlands, Liege, Belgium, Baltimore MD, New Haven CT, USA		  87
14:30  CARDIOVERSION OF ATRIAL FIBRILLATION AFTER THE EXCLUSION OF ATRIAL THROMBI BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY: SUCCESS RATE AND EMBOLIC RISK IN 127 PATIENTS WITH AND WITHOUT HEART FAILURE
J. Wagner, R. Griebenow, L.I. Kraemer, G. Quinkler, B. Hoeltmann, Cologne, Germany		  88
14:45  PROGNOSTIC VALUE OF THE CHARACTERISTICS OF NON-SUSTAINED TACHYCARDIA IN PATIENTS WITH NON-ISCHEMIC HEART FAILURE
E. (H) Hatzinikolaou, I. Kaprinis, E. Reppas, E. Boudioukos, N. Kabouridis, G. Katsaris, Thessaloniki, Greece		  88
15:00  PROGNOSTIC VALUE OF LEFT VENTRICULAR SYSTOLIC ASYNCHRONY AND MALIGNANT VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH DILATED CARDIOMYOPATHY
M. Gessner, G. Blazek, C. Dornaus, W. Kainz, H. Nobis, M. Gruska, E. Kunschitz, G. Gaul, Vienna, Austria		  88
15:15  AICD IN HEART FAILURE: IMPACT WITH AGGRESSIVE MEDICAL THERAPY
K. Akosah, W. Brown, A. Schaper, K. Briggs, J. Lenarz, S. Devine, R. Sundaram, La Crosse WI, USA		  88
15:30  HEART RATE AND HEART RATE VARIABILITY - NON-INVASIVE PREDICTORS OF MORTALITY IN PATIENTS WITH POSTINFARCTION LEFT VENTRICULAR DYSFUNCTION TREATED ACCORDING TO CURRENT GUIDELINES
J. Ruta, P. Ptaszynski, J.K. Wranicz, M. Maciejewski, M. Rosiak, Lodz, Poland		  89
15:45  FOLLOWED 1,196 CHAGASIC PATIENTS WITH TOTAL AV BLOCK FOR 26 YEARS AFTER PACEMAKER IMPLANT
O.T. Greco, A. Cardinalli Neto, R.V. Ardito, A.M. Lorga, Sao Jose Rio Preto, Brazil		  89
16:00  Coffee Break  
TUESDAY, JULY 11, 2000
14:00-16:30    HALL D
S66:  Session:
ACUTE MYOCARDIAL INFARCTION: BASIC RESEARCH AND CLINICAL ASPECTS
Chairpersons: B.I. Jugdutt, Edmonton Alberta, Canada 
A. Lahiri, Harrow Middlesex, UK		  
    Abstract Page
14:00  QUANTIFICATION OF LEFT VENTRICULAR SHAPE CHANGE USING THREE-DIMENSIONAL ECHOCARDIOGRAPHY
S. Wong, M. Hubka, J. McDonald, E. Bolson, F. Sheehan*, Seatle WA, USA 		 89
14:15  CHRONICAL USE OF GROWTH HORMONE INCREASES THE ACTION POTENTIAL DURATION IN RATS WITH MYOCARDIAL INFARCTION
J.G. Mill, C.M. Leite, G.N. Nascimento, R.N. Suave, G. Povoa, Vitoria, Brazil		  89
14:30  EFFECT OF INTERCELLULAR ADHESION MOLECULE-1 ON MYOCARDIAL INFARCTION AND VENTRICULAR REMODELING IN THE MOUSE MODEL
B. Metzler, C. Schaber, J. Mair, F. Hintringer, O. Pachinger, Q. Xu, Innsbruck, Austria 		 90
14:45  WOMEN ARE AT HIGHER RISK OF DEATH THAN MEN IN THE SHORT-TERM AFTER MYOCARDIAL INFARCTION (MI) BUT NOT IN THE LONG-TERM: RESULTS FROM GISSI DATABASES
M.G. Franzosi, L. Santoro, Milan, Italy		  90
15:00  NON-INVASIVE ASSESSMENT OF REPERFUSION FOLLOWING FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION
I.B.A. Menown, J. Allen, J. Anderson, A.A.J. Adgey, Belfast, UK 		 90
15:15  DOUBLE BOLUS OF 750000 I.U. OF STREPTOKINASE - A NEW THROMBOLYTIC REGIMEN, MORE EFFICIENT THAN THE STANDARD 1500000 I.U. IN 60 MINUTES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, C. Teodorescu, M. Guran, M.Dan, P. Capraru, A. Tatu-Chitoiu, A. Bumbu, O. Istratescu-Wolkowski, M. Dorobantu, Bucharest, Romania 		 90 
15:30  INCIDENCE OF HAEMORRHAGIC STROKE IN FIBRINOLYTIC TREATED PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION. TIM STUDY: A SUBGROUP ANALYSIS
L. Lopez, J.M. Cruz, A. Cabades, A. Castro, D. Garcia, V. Lopez, L. Martin, J. Velasco, C. Navas, F. Torres, C. Kalmeller 		 91
15:45  INFLUENCE OF THROMBOLYTIC THERAPY ON THE INCIDENCE OF LEFT VENTRICULAR THROMBI AFTER ACUTE ANTERIOR MYOCARDIAL INFARCTION: ROLE OF SUCCESSFUL REPERFUSION
M. Ileri, E. Yetkin, I. Tandogan, I. Hisar, F. Kosar, S. Korkmaz, S. Goksel, Ankara, Turkey 		 91
16:00  PREDICTION OF FRAME COUNTS 90 MINUTES AFTER THROMBOLYSIS BY MYOCARDIAL PROTEIN LEVELS AT RPESENTATION
K. Ramanathan, J.K. French, S.O.M. Manda, J.T. Stewart, H.D. White, Auckland, New Zealand 		 91
16:15  PREDICTORS OF LEFT VENTRICULAR THROMBUS FORMATION IN PATIENTS WITH ANTERIOR MYOCARDIAL INFARCTION: ROLE OF ACTIVATED PROTEIN C RESISTANCE
E. Yetkin, A.R. Erbay, M. Ileri, S. Ayaz, A. Yanik, G. Yetkin, I. Tandogan, S. Cehreli, S. Korkmaz, S. Goksel, Ankara, Turkey		  91
16:30  Coffee Break  
TUESDAY, JULY 11, 2000
16:15-18:30    HALL A
PL09:  Plenary Session:
NEW HORIZONS IN THE MANAGEMENT OF HEART FAILURE
Chairpersons: M.R. Johnson, Chicago IL, USA 
M.J. Sole, Toronto ON, Canada		  
    Abstract Page
16:15  NEW THERAPIES FOR CONGESTIVE FAILURE IN CHILDREN (Invited Lecture)
R.D. Ross, Detroit MI, USA 		 92
16:30  NEW STRATEGIES FOR THE THERAPY OF INFLAMMATORY CARDIOMYOPATHY ON THE BASIS OF HISTOLOGICAL, IMMUNOHISTOLOGICAL AND VIROLOGICAL ANALYSIS OF MYOCARDIAL BIOPSIES (Invited Lecture)
H.-P. Schultheiss, Berlin, Germany		  92
16:45  THE CHANGING CHALLENGES OF TREATING CONGESTIVE HEART FAILURE AS WE ENTER THE 21ST CENTURY (Invited Lecture)
M.R. Johnson, Chicago IL, USA		  92
17:00  THE FAILING MYOCARDIUM IS NUTRITIONALLY DEFICIENT (Invited Lecture)
M.J. Sole, M. Keith, A. Ball, R. Kurian, K.N. Jeejeebhoy, Toronto ON, Canada		  92
17:15  REFRACTORY HEART FAILURE (RHF): NEW CONCEPT OF MEDICAL MANAGEMENT AND RISK STRATIFICATION (Invited Lecture)
B. Stanek, Vienna, Austria		  93
17:30  CONTINUED TAILORED THERAPY FOR ADVANCED HEART FAILURE USING NON-INVASIVE IMPEDANCE CARDIOGRAPHY (Invited Lecture)
F.W. Smart, C. Young, M. Khalid, H.O. Ventura, New Orleans LA, USA 		 93
17:45  WHAT HAVE WE LEARNED FROM THE NORDIL STUDY? NORDIL - NORDIC DILTIAZEM STUDY (Invited Lecture)
P. Lund-Johansen, Bergen, Norway		  93
18:00 HERBAL, MEGAVITAMIN AND NUTRITIONAL SUPPLEMENT (NATUROCEUTICAL) CONSUMPTION BY HEART FAILURE PATIENTS (Invited Lecture)
D.D. Hermann, J.J. Kuiper, R. Shabetai, D. Carethers, D.J. Shaw, B.H. Greenberg, San Diego CA, USA 		 93
18:15   CARDIAC PATIENT MANAGEMENT GUIDED BY EXERCISE PARAMETERS (Invited Lecture)
Y. Charuzi, T.K. Nishibun, T.W. Lang, Los Angeles CA, USA		  94
TUESDAY, JULY 11, 2000
16:15-18:15    HALL B
S67:  Session:
MOLECULAR BIOLOGY AND BIOCHEMICAL ASPECTS OF HEART FAILURE
Chairpersons: R.N.A. Gasser, Graz, Austria 
P.K. Singal, Winnipeg MB, Canada		  
    Abstract Page
16:15  AT II ANTAGONISM INHIBITS THE ELABORATION OF CHEMOKINES WHICH CONTRIBUTE TO CELL PROLIFERATION AND PLAQUE FORMATION IN RESPONSE TO INJURY FROM OX-LDL (Invited Lecture)
A. Simonini, B. Pitt, M. Aviram, R.M. Strieter, Los Angeles, CA, USA		  94
16:30  TROPONIN I ELEVATION DETERMINES THE PROGNOSIS OF ACUTE PULMONARY EMBOLISM
F. Post, T. Voigtlaender, D. Mertens, D. Peetz, B. Nowak, Mainz, Germany		  94
16:45  ENHANCED ADP-RIBOSYLATION AND THE POSSIBILITIES OF PROTECTION IN MYOCARDIAL DAMAGE CAUSED BY REACTIVE OXYGEN SPECIES
T. Habon, E. Szabados, K. Toth, B. Sumegi, Pecs, Hungary		  94
17:00  INSERTION/DELETION POLYMORPHISM IN THE ANGIOTENSIN CONVERTING ENZYME GENE AFFECTS HEART WEIGHT
K.-I. Nakahara, M. Nishinaga, S. Matsushita, Itabashi-Ku, Japan		  95
17:15  HEART TRANSPLANTATION IN PATIENTS WITH INHERITED MYOPATHIES ASSOCIATED WITH END-STAGE CARDIOMYOPATHY: MOLECULAR AND BIOCHEMICAL DEFECTS ON CARDIAC AND SKELETAL MUSCLE
P. Melacini, A. Gambino, A. Caforio, A. Barchitta, M.L. Valente, A. Angelini, M. Fanin, G. Thiene, C. Angelini, G. Casarotto, G.A. Danieli, S. Dalla Volta, Padua, Italy 		 95
17:30  BIOCHEMICAL CHARACTERISATION OF PHOSPHODIESTERASE TYPE 5 (PDE5) EXPRESSION IN HUMAN CORPUS CAVERNOSUM (CC) AND CARDIAC VASCULAR TISSUE, AND CELLULAR LOCALISATION BY IMMUNOHISTOCHEMISTRY (IHC) AND IN SITU HYBRIDISATION (ISH)
C. McGrouther, R.G. Charlton, L. Thompson, F. Burslem, S. Philips, D.V. Parums, Sandwich, Newcastle-upon-Tyne, Cambridge, UK 		 95
17:45  CHRONIC HUMAN ATRIAL FIBRILLATION DOWN-REGULATES INWARD RECTIFIER POTASSIUM CURRENT IK,ACH INDEPENDENT OF G-PROTEIN BETA3-SUBUNIT C825T-POLYMORPHISM
D. Dobrev, A. Kortner, E. Graf, H.M. Himmel, E. Wettwer, S. Schueler, U. Ravens, Dresden, Germany 		 95
18:00  STUDY ON ATRIAL NATRIURETIC FACTOR IN HUMAN PERICARDIUM
S.J. Wen, J.W. Zhang, C.J. Wang, F. Fang, Y.H. Wang, J. Wen, T.B. Chen, Z.G Hong, Bejing, China		  96
TUESDAY, JULY 11, 2000
16:15-18:00    HALL C
S68:  Session:
INTERVENTIONAL CARDIOLOGY IN ACUTE INFARCTION AND ANGINA
Chairpersons: R.R. Makkar, Los Angeles CA, USA
T.K. Rosengart, Evanston IL, USA		  
    Abstract Page
16:15  MECHANISMS OF FAILED PRIMARY PTCA FOR ACUTE MI
A.M.A. Hasnie, C.L. Grines, W.W. O'Neill, E. Garcia, B. Brodie, G. Stone, Royal Oak MI, USA		  96
16:30  LONG TERM FOLLOW-UP AFTER PRIMARY STENTING VERSUS ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION
B. Scheller, B. Hennen, S. Severin-Kneib, H. Schieffer, T. Markwirth, Homburg/Saar, Germany 		  96

 
16:45  INSERTION OF A NEW PHOSPHORYLCHOLINE COATED MINI-STENT (2/10 MM) IN VERY SMALL CORONARY ARTERIES DURING PERCUTANEOUS CORONARY INTERVENTION (PCI)
E. Grenadier, I. Lashevsky, A. Roguin, M. Boulos, S. Amikam, S. Cohen, A. Kerner, R. Beyar, Haifa, Israel		  96
17:00  REGIONAL DIASTOLIC DYSFUNCTION DURING ACUTE MYOCARDIAL ISCHEMIA CAUSED BY BALLOON ANGIOPLASTY
O. Yuko, I. Hitoshi, H. Shigetaka, N. Wataru, K. Hirofumi, Okazaki, Japan		  97
17:15  IMPACT OF CILOSTAZOL ON REDUCTION RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
J. Azuma, E. Tsuchikane, T. Kobayashi, N. Awata, Osaka, Japan 		 97
17:30  PERCUTANEOUS TRANSMYOCARDIAL YAG LASER (PTMR) IN SEVERE CHRONIC CAD: SUBJECTIVE AND OBJECTIVE SIX MONTH FOLLOW-UP
M. Viecca, A. Colombo, E. Piccaluga, R. Seregni, P. Danna, S. Porcellini, L. Pastori, M. Turiel, S. Muzzupappa, C. Antona, Milan, Italy 		 97
17:45  CUTTING BALLOON ANGIOPLASTY. AN OPTIMAL TREATMENT MODALITY FOR SMALL VESSELS AND RESTENOSIS?
R. Lowe, J.D. Somauroo, S. Osula, P. Heath, R.A. Perry, Liverpool, UK		  97
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P401:  Poster Session:
ROLE OF APOPTOSIS IN DILATED CARDIOMYOPATHY		  
Board No.    Abstract Page
  SFAS LIGAND; -RECEPTOR, AND CYTOKINES IN MYOCARDITIS AND DCM - CORRELATION TO APOPTOSIS?
P. Alter, E. Meyer, M. Jobmann, B. Maisch, Marburg/Lahn, Germany		  98
2  ROLE OF APOPTOSIS IN MYOCARDITIS AND DILATED CARDIOMYOPATHY - AN ENDOMYOCARDIAL BIOPSY STUDY
P. Alter, M. Jobmann, E. Meyer, B. Maisch, Marburg/Lahn, Germany		  98
3  CASPASE INHIBITORS MAY REDUCE MYOCARDIAL ISCHEMIC INJURY IN THE ISOLATED RABBIT HEART THROUGH AN APOPTOSIS-INDEPENDENT MECHANISM
W.R. Tracey, W.P. Magee, J.G. Chapman, H.A. Stukenbrok, A.J. Milici, Groton CT, USA		  98
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P402:  Poster Session:
NATRIURETIC PEPTIDE IN HEART FAILURE		  
Board No.    Abstract Page
4  LONG ACTING NATRIURETIC PEPTIDE, VESSEL DILATOR AND KALIURETIC PEPTIDE ENHANCE URINARY EXCRETION RATE OF b2 MICROGLOBULIN IN CONGESTIVE HEART FAILURE
D.L. Vesely, G.I. Perez-Lamboy, D.D. Schocken, Tampa FL, USA 		 98
5  CARDIAC EVENTS AND PLASMA NATRIURETIC PEPTIDES IN PATIENTS WITH CHRONIC HEMODIALYSIS
T. Goto, H. Takase, T. Toriyama, K. Hayashi, H. Masuda, Y. Kurita, Y. Dohi, Hamamatsu, Japan 		 99
6  ADRENOMEDULLIN AND RELAXIN IN NEUROHUMORAL REGULATION OF HEART DISEASE. A COMPARISON WITH NATRIURETIC PEPTIDES
H. Lapp, I. Krakau, J.P. Stasch, G. Boerrigter, H. Gulker, Wuppertal, Germany		  99
7  EFFECT OF CONCENTRATION OF ANF IN PF ON CARDIAC FUNCTION IN PATIENTS WITH HEART DISEASE
S. Wen, Y. Wang, W. Wang, Beijing, China		  99
8  INCREASED PLASMA BRAIN NATRIURETIC PEPTIC AFTER CORONARY ARTERY BYPASS GRAFT SURGERY
C. Gurgun, M. Zoghi, O. Saribulbul, E. Ercan, F. Ozerkan, C. Cinar, C. Turkoglu, Izmir, Turkey		  99
9  EFFECT ON PLASMA ATRIAL AND BRAIN NATRIURETIC PEPTIDE LEVELS OF ENDOSCOPIC TRANSTHORACIC SYMPATHICOTOMY IN HUMANS
Y. Nakamura, H. Yoshizawa, M. Hirasawa, M. Sendai, H. Kida, Y. Matsumoto, Kanazawa, Japan 		 100
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P403:  Poster Session:
PHARMACOLOGIC MODULATION OF VASCULAR-ENDOTHELIAL FUNCTION		  
Board No.    Abstract Page
10  ALTERATION OF EXPRESSION OF ADHESION MOLECULES BY STATINS
A. Rezaie-majd, J. Wojta, H.G. Kress, T. Maca, E. Minar, M. Baghestanian, Vienna, Austria		  100
11  IMPROVEMENT IN WALKING DISTANCE AND QUALITY OF LIFE IN PERIPHERAL ARTERIAL DISEASE BY A MEDICAL FOOD
A.J. Maxwell, B. Anderson, J. Cooke, Belmont, Stanford CA, USA		  100
12  IS THE ANTIAGGREGAN EFFECT OF STATINS INDEPENDENT OF THE LIPID LOWERING LEVELS?
C. Ceyhan, C. Gurgun, E. Ercan, M. Zoghi, F. Ozerkan, L. Can, C. Turkoglu, Izmir, Turkey 		 100
13  THE INFLUENCE OF NO-GROUP DONOR - SODIUM NITROPRUSSIDUM IN BUCCAL DRUG FORM ON SILENT MYOCARDIAL ISCHEMIA IN PATIENTS WITH CORONARY ARTERY DISEASE ASSOCIATED WITH NITRATE TOLERANCE
I.K. Ketchin, S.I. Ketchin, Zaporozhye, Ukraine		  101
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P404:  Poster Session:
NUCLEAR CARDIOLOGY: MYOCARDIAL PERFUSION, FUNCTION AND VIABILITY		  
Board No.    Abstract Page
14  DUAL ISOTOPES (TI-201 and I-123 BMIPP) SPECT STUDIES IN DETECTING MYOCARDIAL SALVAGE EFFECTS OF ACUTE MYOCARDIAL INFARCTION WITH VARIOUS REPERFUSION THERAPIES
T. Furuta, J. Wang, T. Kondo, W. Fujieara, S. Mori, H. Yokoi, Y. Abo, Y. Watanabe, Nagoya, Japan		  101
15  PROGNOSTIC VALUE OF 99M-TC-SESTAMIBI MYOCARDIAL PERFUSION IMAGING IN PATIENTS WITH SUSPECTED CAD
C.R. Kuehn, S. Kasischke, C. Fuensterer, T. Rau, D. Mathey, J. Schofer, Hamburg, Germany		  101
16  NEGATIVE INFLUENCES OF PHENYLEPHRINE INFUSION ON PERFUSION SCINTIGRAPHY IN CORONARY ARTERY DISEASE PATIENTS
A. Antonopoulos, D. Nikolopoulos,, E. Georgiou, T. Markoulis, P. Santas, M. Kyriakidis, C. Proukakis, Athens, Greece		  101
17  INCREASED PROGNOSTIC VALUE OF GATED-SPECT STUDIES WITH 99MTC-TETROFOSMIN, IN PATIENTS WITH HIGH, MEDIAL AND LOW PRE-SCAN LIKELIHOOD OF CAD
M. Pabon, D. Paez, M. Badiel, Cali, Colombia 		 102
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P404:  Poster Session:
NUCLEAR CARDIOLOGY:
MYOCARDIAL PERFUSION, FUNCTION AND VIABILITY (cont'd)		  
Board No.    Abstract Page
18  ASSESSMENT OF LEFT VENTRICULAR FUNCTION IN PATIENTS WITH VENTRICULAR ANEURYSM BY RADIONUCLIDE ANGIOGRAPHY, TWO-DIMENSIONAL ECHOCARDIOGRAPHY AND CONTRACT ANGIOGRAPHY: COMPARISON OF METHODS
C. Ginghina, E. Apetrei, G. Jovin, B. Fotiade, I. Ene, I. Kulcsar, D. Qeshta, M. Marinescu, Bucharest, Romania 		 102
19  ABNORMAL SPECT MYOCARDIAL PERFUSION IMAGING DURING PERIODS OF OBSTRUCTIVE SLEEP APNEA IN MORBIDLY OBESE PATIENTS WITHOUT KNOWN HEART DISEASE
A. Orea, M. Valencia, V. Rebollar, A. Castano, C. Keirns, J. Gonzalez-B, J. Dorantes, R. Narvaez, J. Sepulveda, J. Oseguera, O. Gonzalez, G. Garcia, Mexico City, Mexico 		 102
20  POSITRON EMISSION TOMOGRAPHY AND ANGIOGRAPHY: CORRELATION BY CORONARY TERRITORY IN CHILDREN WITH SUSPECTED CORONARY ABNORMALITIES
M. Hernandez Pampaloni, V. Allada, H.R. Schelbert, Los Angeles CA, USA		  102
21  MYOCARDIAL PERFUSION BY SPECT Tc 99m SESTAMIBI IN LEFT BUNDLE BRANCH BLOCK OR ANTERIOR HEMIBLOCK. ANGIOGRAPHIC CORRELATION
V. Rebollar, A. Orea, J. Dorantes, V. Ochoa, R. Navarrete, C. Keirms, A. Rangel, J. Oseguera, J. Sepulveda, O. Gonzalez, Mexico City, Mexico 		 103
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P405:  Poster Session:
INTERVENTIONAL CARDIOLOGY IN ACUTE INFARCTION AND ANGINA		  
Board No.    Abstract Page
22  PERCUTANEOUS CORONARY REVASCULARIZATION IN THE ELDERLY
R. Lowe, J.D. Somauroo, J.R. Pyatt, P. Heath, R.A. Perry, Liverpool, UK		  103
23  RECURRENT STENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION IS INFLUENCED BY HYPERGLYCEMIA AND -INSULINEMIA IN DIABETICS
J.B. Dahm, A. Feldrappe, M. Reiter, Greifswald, Germany		  103
24  TRANSPORT FOR PRIMARY PTCA
P. Widimsky, L. Groch, M. Zelizko, M. Aschermann, F. Bednar, Prague, Czech Republic 		 103
25  DECISION MAKING IN AMBIGUOUS LEFT-MAIN-STENOSIS: GUIDANCE BY INTRAVASCULAR ULTRASOUND
T. Twisselmann, M. Weisbach, K. Hertting, R. Kuechler, K.-H. Kuck, Hamburg, Germany		  104
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P405:  Poster Session:
INTERVENTIONAL CARDIOLOGY IN ACUTE INFARCTION AND ANGINA (cont'd)		  
Board No.    Abstract Page
26  DEVELOPMENT OF VBPS, A VASCULAR BRACHYTHERAPY PLANNING SYSTEM
M. Bevegni, F. Bisi, L. Andreucci, R. Anselmi, Genoa, Italy 		 104
27  DYNAMIC STATUS OF LEFT VENTRICLE SIZE AND EJECTION FRACTION AFTER PERCUTANEOUS CORONARY ANGIOPLASTY FOR PATIENTS WITH DIFFERENT STAGES OF ISCHEMIC HEART DISEASE
S. Rutiene, R. Unikas, Kaunas, Lithuania 		 104
28  ANGIOGRAPHIC RESULTS AND LATE CLINICAL FOLLOW-UP AFTER BARD-XT INTRACORONARY STENT IMPLANTATION
R.R.L. Bueno, E.E. Guerios, J.C. Tarastchuk, P.M.P. de Andrade, D.C. Nercolini, A.L.A. Pacheco, Curitiba, Brazil		  104
29  PRIMARY CORONARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION: LONG TERM CLINICAL FOLLOW UP RESULTS
N. Delarche, G. Laplace, M. Rougier, J.L. Banos, G. Estrade, Pau, France		  105
30  PRIMARY CORONARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT STENTING: LONG TERM FOLLOW UP RESULTS
N. Delarche, G. Laplace, M. Rougier, J.L. Banos, G. Estrade, Pau, France		  105
31  INFLUENCE OF STENT LENGTH ON THE OUTCOMES OF CORONARY STENT IMPLANTATIONS
M. Gencbay, K. Sonmez, M. Degertekin, F. Turan, Istanbul, Turkey		  105
32  MULTIPLE VESSEL DILATATION IN THE COURSE OF ACUTE MYOCARDIAL INFARCTION (AMI): ANATOMY-BASED OR COST-BASED DECISION?
M. Sansa, G. Giacomarra, P. Bergamo, A.S. Bongo, A. Campi, M. Brambilla, C. Cernigliaro, Novara, Turin, Italy		  105
33  ARTERIAL ACCESS SITE CLOSURE WITH A NOVEL SEALING DEVICE: DUETT™
G. Heyer, K. Atzenhofer, H. Meixl, H. Wallner, B. Strohmer, C. Lampersberger, Salzburg, Austria 		 106
34  EFFICACY AND SAFETY OF INTRAVASCULAR ULTRASOUND-GUIDED BALLOON ANGIOPLASTY FOR TREATMENT OF IN-STENT RESTENOSIS
T. Sakamoto, T. Kawarabayashi, T. Sano, Y. Nishibori, H. Taguchi, A. Tanaka, Y. Nishida, Sakai, Japan		  106
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P406:  Poster Session:
SECONDARY PREVENTION OF CORONARY ARTERY DISEASE		  
Board No.    Abstract Page
35  LONG-TERM FOLLOW-UP OF THE ORGANIC NARROWING IN PATIENTS WITH VASOSPASTIC ANGINA
M. Watarai, H. Horibe, T. Hidaka, K. Takemoto, S. Shimizu, Y. Shiga, F. Takatsu, Anjo, Aichi, Japan		  106
36  EFFECTS OF PRAVASTATIN ON ENDOTHELIAL FUNCTION AND CARDIOVASCULAR EVENTS IN HYPERLIPIDEMIA
X. Zeng, Y. Lee, X. Zeng, H. Zeng, Chengdu, China		  106
37  RELATIONSHIP BETWEEN PLASMA HIGH DENSITY LIPOPROTEIN LEVELS AND PATIENT'S COMPLIANCE
C. Sekuri, Z. Kurhan, O. Utuk, O. Bayturan, H. Gocer, T. Tavli, B. Kiliccioglu, Manisa, Turkey 		 107
38  PROGRESSION OF CORONARY ARTERY DISEASE: THE ANALYSIS OF 74 PATIENTS WHO HAD UNDERGONE AT LEAST TWO CORONAROGRAPHIES
E. Apetrei, C. Ginghina, S. Maximeasa, D. Qeshta, I. Kulcsar, D. Deleanu, L. Zarma, B. Fotiade, Bucharest, Romania		  107
39  LEFT VENTRICLE DIASTOLIC FUNCTION PARAMETER (E/A RATIO) TO CALCULATE PROBABILITY OF IHD IN PATIENTS WITH NIDDM
A. Mrochek, D. Goncharik, Minsk, Belarus 		 107
40  SYMPATHETIC PREDOMINANCE IN PATIENTS WITH NIDDM PREDISPOSES TO MYOCARDIAL ISCHEMIA DURING DAILY ACTIVITY REGARDLESS OF NEGATIVE EXERCISE TEST
A. Mrochek, D. Goncharik, Minsk, Belarus		  107
41  IS LONGTERM PROGNOSIS IN ACUTE MYOCARDIAL INFARCTION INFLUENCED BY EARLY SHORT TERM PHYSICAL TRAINING
S.N. Marcus, R.V. Cioranu, D.I. Gherasim, L.I. Florea, C.T. Ginghina, E. Apetrei, Bucharest, Romania		  108
42  ADULTS IN POLAND UNDERESTIMATE CARDIOVASCULAR RISKS OF SEDENTARY LIFESTYLE AND PROFITS OF REGULAR PHYSICAL ACTIVITY
T. Zdrojewski, M. Kakol, K. Kozicka, B. Wyrzykowski, B. Krupa-Wojciechowska, Gdansk, Poland		  108
43  IS SULPHUREOUS WARM WATER BATH CONTRAINDICATED BY CHRONIC HEART FAILURE?
J. Lukac, L. Adamovic, M. Sitar, J. Celko, A. Makis, Trencianske Teplice, Dubnica nad Vahom, Slovak Republic		  108
44  LONG-TERM (25 YEARS) EFFICACY OF COMPREHENSIVE POST MYOCARDIAL INFARCTION REHABILITATION PROGRAM. INFLUENCE ON HEART FAILURE
S.I. Marcus, R.V. Cioranu, E. Apetrei, Bucharest, Romania 		 108
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P407:  Poster Session:
NURSING ASPECTS OF HEART FAILURE		  
Board No.    Abstract Page
45  FACILITATING CHANGE: EMPOWERING THROUGH EDUCATION
C. Draus, D. Barraco, C. Westphal, L. Heckman, A. Walblay, M. Franklin, M. Massender, Dearborn MI, USA		  109
46  IMPROVING CARE AT END OF LIFE FOR HEART FAILURE PATIENTS
C. Westphal, G. Daly, A. Walblay, Dearborn MI, USA 		 109
47  PARTNERING FOR HEART FAILURE: A CLINIC WITHOUT WALLS
A. Walblay, C. Draus, D. Barraco, Dearborn MI, USA		  109
48  OPTIMISING THE CARE OF IN-PATIENTS WITH HEART FAILURE: THE ROLE OF THE HEART FAILURE NURSE
N.D. Palmer, B. Appleton, E.A. Rodrigues, Liverpool, UK		  109
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P408:  Poster Session:
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY II		  
Board No.    Abstract Page
49  FIRST OCCURRENCE OF PAROXYSMAL ATRIAL FIBRILLATION IN PATIENTS IMPLANTED WITH PREFORMED VS NON PREFORMED ATRIAL LEADS
A. Spampinato, M. Martelli, G. Bruni, C. Pignalberi, M. Pepe, F. De Seta, F. Bellocci, Rome, Italy		  110
50  THE PROLONGED P-WAVE DURATION ON SIGNAL AVERAGED ELECTROCARDIOGRAM IS A GOOD PREDICTOR OF ATRIAL FIBRILLATION AFTER CORONARY ARTERY BYPASS SURGERY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION
P. Ptaszynski, J. Ruta, M. Maciejewski, H. Bolinska, A. Iwaszkiewicz-Zaslonka, R. Jaszewski, J. Zaslonka, Lodz, Poland		  110
51  ROLE OF CARDIAC SYSTOLIC DYSFUNCTION IN ARRHYTHMOGENESIS
M. Guo, Z. Wang, M.Y. Sai, Urumqi, Xinjiang, China 		 110
52  A NEW APPROACH TO ELUCIDATE THE MECHANISM OF WIDE QRS COMPLEX TACHYCARDIA FOLLOWING ENTRAINMENT BY RIGHT VENTRICULAR APEX STIMULATION
J.L. Merino, R. Peinado, I. Fernandez-Lozano, L. Ramirez, I. Echeverria, J.A. Sobrino, Madrid, Spain		  110
53  LU 135.252, THE SELECTIVE ENDOTHELIN A-RECEPTOR ANTAGONIST INHIBITS THE DIRECT ARRHYTHMOGENIC ACTION OF ENDOTHELIN-1
T. Szabo, L. Geller, B. Merkely, M. Raschack, A. Juhasz-Nagy, Budapest, Hungary, Ludwigshafen, Germany		  111
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P408:  Poster Session:
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY II (cont'd)		  
Board No.    Abstract Page
54  CLINICAL PROFILE OF PATIENTS WITH ASYMPTOMATIC HYPERDENSE PREMATURE VENTRICULAR DEPOLARIZATION
A.C.F. De Lara-Llarena, B.P. Calderon, R.E. Ramboyong, D.R. Flores Jr., E.S. Caguioa, Manila, Philippines		  111
55  COMPARISON OF HEMODYNAMIC EFFECTS OF LIDOCAINE AND DISOPYRAMIDE AT REST AND DURING RIGHT VENTRICULAR PACING IN PATIENTS WITH CORONARY ARTERY DISEASE
H.-J. Odenthal, M. Konermann, B. Sanner, Rheine, Herne, Bochum, Germany		  111
56  SINGLE DOSAGE OF MAGNESIUM SULFATE FOR PREVENTION OF POSTOPERATIVE ATRIAL TACHYARRHYTHMIA AFTER HEART SURGERY
H.-G. Wollert, H. Grossmann, B. Malowsky, H. Grubitzsch, L. Eckel, Karlsburg, Germany		  111
57  MIXED A/B AND SELECTIVE A ENDOTHELIN RECEPTOR ANTAGONISTS PREVENT INTRAPERICARDIAL ENDOTHELIN-1 INDUCED VENTRICULAR ARRHYTHMIAS
L. Geller, B. Merkely, T. Szabo, O. Kiss, M. Raschack, A. Juhasz-Nagy, F. Horkay, Budapest, Hungary, Ludwigshafen, Germany 		 112
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P409:  Poster Session:
MISCELLANEOUS		  
Board No.    Abstract Page
58  HYPERINSULINEMIA AND INSULIN RESISTANCE CAUSE POSTURAL HYPOTENSION IN TYPE II DIABETES
D. Liu, Z. Zhu, J. Zhu, Chongqing, China 		 112
59  HEART RATE RESPONSE RELATED TO MYOELECTRIC ACTIVITY DURING ISOMETRIC EXERCISE IN NORMAL MEN
E. Silva, L.A. Milan, L. Oliveira, A.M. Catai, V.R.F.S. Maraes, L. Gallo Jr., Sao Carlos, Ribeirao Preto, Brazil		  112
60  FREE RADICAL & VITAMIN E IN ACUTE MYOCARDIAL INFARCTION
N. Nand, N. Budhiraja, G.P. Singh, S. Kharab, Rohtak, India 		 112
61  ROLE OF LUPUS ANTICOAGULANT AND OTHER THROMBOGENIC FACTORS IN PATHOGENESIS OF ACUTE MYOCARDIAL INFARCTION AT YOUNG PATIENTS
D. Qeshta, C. Carp, C. Ginghina, I. Kulcsar, C. Ceck, D. Colita, V. Uscatescu, Bucharest, Romania 		 113
62  THE HEART RATE VARIABILITY IN THE CHARACTERIZATION OF THE
SYMPATHETIC AND PARASYMPATHETIC NERVOUS SYSTEM OF HEART
V.R.F.S. Maraes, T.F. Ribeiro, A.M. Catai, L. Oliveira, L. Gallo Jr., E. Silva, Sao Carlo, Ribeirao Preto, Brazil		  113
TUESDAY, JULY 11, 2000
13:30-18:00    POSTER AREA
P409:  Poster Session:
MISCELLANEOUS (cont'd)		  
Board No.    Abstract Page
63  HEART FAILURE WITH NORMAL SYSTOLIC FUNCTION IN GERIATRIC PRACTICE
M.A.V. Gatchalian, E.T. Gatchalian Sr., Manila, Philippines		  113
64  HEART RATE VARIABILITY IN PATIENTS WITH CORONARY HEART DISEASE AND ARTERIAL HYPERTENSION
J.L.P. Rosario, A.M. Catai, E. da Silva, R.M.M. Verzola, L. Gallo Jr., L. de Oliveira, M.S.A. Moura, Ribeirao Preto, Brazil		  113
65  THE EFFECT OF INCREASED LEFT VENTRICULAR END-DIASTOLIC PRESSURE ON DISPERSION OF VENTRICULAR REPOLARISATION
G. Bajraktari, F. Hima, G. Dragusha, B. Zhaxho, S. Qirko, Prishtina, Kosovo, Tirana, Albania		  114
66  CHRONOBIOLOGICAL PECULIARITIES RESISTANCE TO ANTIANGINAL PHARMACOTHERAPY
A.B. Arushanian, T.A. Shamlian, Stravropol, Russia		  114
67  SERUM HEPATOCYTE GROWTH FACTOR AS A POSSIBLE INDICATOR OF ATHEROSCLEROSIS IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Y. Matsumoto, Y. Yoshitomi, S. Kojima, M. Yano, T. Sugi, M. Saotome, M. Kuramochi, Nagasaki City, Japan		  114
68  PLASMA LEVELS OF EXTRACELLULAR MATRIX PROTEINS AS A MARKER OF MYOCARDIAL REMODELING
H. Lapp, I. Krakau, M. Brinkschmidt, B. Homann, M. Gehrmann, M. Voelker, E.R. Burchardt, Wuppertal, Germany		  114
69  NASAL VENTILATION IN CONGESTIVE HEART FAILURE: THE ACUTE HEMODYNAMIC EFFECTS OF BIPAP AND CPAP
J.D. Somauroo, M. Wilkinson, M. Jackson, E. Rodrigues, D.T. Connelly, P.M.A. Calverley, R.M. Angus, Liverpool, UK